Clinical Trial

Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache

Name: Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache — clinical trial record (NCT07714369)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess headache response rate for minimal pain at 30 minutes following zavegepant administration and to assess additional effectiveness and treatment failure endpoints at various timepoints after zavegepant administration

Trial Details

NCT Number	NCT07714369
Lead Sponsor	The University of Texas Health Science Center, Houston Collaborators: Pfizer
Conditions	Cluster Headache
Enrollment	40 participants
Start Date	2026-10-01
Primary Completion	2028-04-01 (estimated)
Study Completion	2028-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-20